European Union merger law

Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

Thursday, July 22, 2021 - 5:49pm

We look forward to presenting our position during the Phase II process, said Charles Dadswell, General Counsel for Illumina.

Key Points: 
  • We look forward to presenting our position during the Phase II process, said Charles Dadswell, General Counsel for Illumina.
  • Illumina is also challenging the ECs jurisdiction to investigate the transaction under Article 22 of the European Union (EU) Merger Regulation.
  • Illumina has filed an action in the General Court of the EU seeking annulment of the ECs jurisdiction to review the acquisition.
  • Illuminas re-acquisition of GRAIL means that millions of citizens across the European Economic Area (EEA) will be able to access life-saving early cancer screening years sooner.